Angiogenin elevates the invasive potential of squamous cell lung carcinoma cells through epithelial‑mesenchymal transition
- Authors:
- Published online on: September 19, 2016 https://doi.org/10.3892/or.2016.5107
- Pages: 2836-2842
Abstract
Introduction
With the advancements in research on mutations in the epidermal growth factor receptor (EGFR) kinase, as well as fusions involving anaplastic lymphoma kinase (ALK), the treatment of patients with lung adenocarcinoma has experienced marked improvement (1,2). Unfortunately, the therapeutic effect of these personalized treatment programs is less obvious in the second most common type of lung cancer, squamous cell lung carcinoma (SQCLC). Hence, it is necessary to identify other significant markers as new targets for SQCLC therapy.
Angiogenin (ANG), a 14,400 Da angiogenic ribonuclease of the RNase A superfamily, is upregulated in a variety of human cancers and has a 33% amino acid identity and an overall homology of 56% to that of RNase-A (3). Angiogenin was once thought to promote cancer progression through its angiogenic activity. However, recent research has demonstrated that ANG can directly stimulate tumor cell proliferation and its expression and activity were found to be upregulated significantly in a variety of human tumors including breast, colorectal, kidney and pancreatic cancers, and this upregulation was found to be correlated with tumor progression and poor prognosis in patients (4). As a transcription factor, ANG cannot be detected in normal, non-endothelial cells (5), however, its expression in human cancer cells and human tumors has not been widely investigated.
More importantly, ANG is implicated in a wide range of biological functions including cell survival, growth, proliferation, migration, tube formation and tumor angiogenesis (6–8).
Epithelial-mesenchymal transition (EMT), a process in which epithelial cells lose or modify their apical-basal polarity and are converted to a mesenchymal phenotype, is a critical process during embryonic development and tumor metastasis (9,10). The process of EMT is typically characterized by losing the expression of the epithelial markers, E-cadherin and β-catenin, which are transmembrane proteins essential for stable adherens junctions, and acquiring the expression of mesenchymal markers, such as N-cadherin, vimentin and TGF-β (11,12). We, therefore, hypothesized that ANG is an inducer of EMT in human squamous cell lung carcinoma and enhances the metastatic potential.
Materials and methods
Tissue collection
The cancerous and corresponding non-tumor normal specimens of SQCLC, freshly frozen for western blot analysis and qRT-PCR, were obtained from 50 patients who underwent lung cancer resection procedures at Changhai Hospital from October, 2012 to October, 2015. All cancerous and matching non-cancerous samples used for this study were provided by the Clinical and Experimental Pathology of the Research Centre of Changhai Hospital, Shanghai, China where initial H&E staining and histologic diagnoses were performed after standard surgical primary tumor resection. This study was conducted in accordance with the Declaration of Helsinki and was approved by the Medical Ethics Committee of Changhai Hospital, with all patients providing written informed consent.
Cell culture
SK-MES-1 cells were obtained from the Cancer Cell Repository (Shanghai Cell Bank, Shanghai, China), and were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% heat-inactivated fetal bovine serum (Gibco-BRL) and antibiotics (100 U/ml penicillin and 100 U/ml streptomycin; Hyclone Laboratories, Inc., Logan, UT, USA) at 37°C in a humidified atmosphere of 5% CO2.
RNA interference and ANG overexpression
The ANG-specific short hairpin RNA adenovirus vector (shANG) and the negative control short hairpin RNA adenovirus vector (shScramble) were purchased from Genechem Co., Ltd. (Shanghai, China). The sequences of shANG were: sense strand 1: 5′-CCGCGGGATGACAGATACTGTGAAGAGATTCACAGTATCTGTCATCCCG-3′ and antisense strand 1: 5′-AACGGGATGACAGATACTGTGAATCTCTTCACAGTATCTGTCATCCCGC-3′; sense strand 2: 5′-CCGGATCCCAGGCTCGTTCTTTGGAGACAAAGAACGAGCCTGGGATCC-3′ and antisense strand 2: 5′-AAGGATCCCAGGCTCGTTCTTTGTCTCCAAAGAACGAGCCTGGGATCC-3′. An adenovirus vector co-expressing ANG (Ad-ANG) and a control empty adenovirus vector (Ad-Null) were constructed using AdEasy system (Genechem Co., Ltd., Shanghai, China).
Quantitative real-time reverse-transcription polymerase chain reaction (qRT-PCR)
Total RNA was extracted and cDNA was synthesized using the PrimeScript RT Reagent kit (Takara Bio). SYBR Premix EX Taq (Takara Bio) was used for quantitative real-time polymerase chain reaction performed using a LightCycler® 480 Real-Time PCR system (Roche Diagnostics). The primers for each gene were as follows: 18S rRNA forward: 5′-CGGACACGGACAGGATTGAC-3′; 18S rRNA reverse: 5′-GCATGCCAGAGTCTCGTTCG-3′; ANG forward: 5′-GGACTTGTTCTGAGGCCGAG-3′; ANG reverse: 5′-CCAGCACGAAGACCAACAAC-3′. The amplification conditions were as follows: 1 cycle of 95°C for 30 sec and 40 cycles of 95°C for 5 sec followed by 60°C for 30 sec. The expression levels of the target genes relative to the control were determined using the 2−ΔΔCT method. 18S rRNA served as the internal control.
Western blot analysis
Western blot analyses were performed as previously described (13). The primary antibodies included: angiogenin (Sc-74528, Santa Cruz Biotechnology, Inc., 1:1,000), vimentin (ab92547, Abcam, 1:2,000), TGF-β1 (ab92486, Abcam, 1:1,000), E-cadherin (ab40772, Abcam, 1:10,000) and β-catenin (60008-1-Ig, Proteintech, 1:2,000).
Immunohistochemistry
Immunohistochemical assay was performed as previously described (14). The primary antibodies used were: angiogenin (Sc-74528, Santa Cruz Biotechnology, Inc., 1:100), vimentin (ab92547, Abcam, 1:200), TGF-β1 (ab92486, Abcam, 1:100), E-cadherin (ab40772, Abcam, 1:500), N-cadherin (ab12221, Abcam, 1:500), and β-catenin (ab32572, Abcam, 1:500).
Immunofluorescence
Paraformaldehyde-fixed SK-MES-1 cells were first incubated with primary antibodies at 4°C overnight. After being washed three times with PBS, the cells were incubated with secondary antibodies for 1 h at 37°C. Nuclei were counterstained with 4′,6-diamidino-2-phenylindole (DAPI) for 2 min. The primary antibodies used were angiogenin (Sc-74528, Santa Cruz Biotechnology, Inc., 1:1,000), E-cadherin (ab40772, Abcam, 1:500) and N-cadherin (ab12221, Abcam, 1:500). The secondary antibodies used were Alexa Fluor 498-conjugated anti-rabbit IgG (1:400, Jackson ImmunoResearch).
Scratch assay
Cells were placed in a 24-well plate at an initial density of 1×105 cells/well. A uniform monolayer formed in 2–3 days. All wound-healing assays were performed in a serum-free medium. Thirty-six hours after infection, a micro-pipette tip was used to create a wound in the monolayer by scraping. Images were captured at 24 h after the scratch and the migrated cells were quantitated.
Invasion assay
The invasion assay was performed using Transwell insert chambers with a pore size of 8 µm (Corning). The Transwell filter inserts were coated with Matrigel; 0.5×105 cells were seeded in serum-free medium in the upper chamber. After a 24-h incubation at 37°C, cells in the upper chamber were carefully removed with a cotton swab and the cells that had traversed the membrane were fixed, stained in a 0.1% crystal violet solution and counted.
Cell proliferation
Cell proliferation was analyzed using a Cell Counting Kit-8 (Beyotime, China). Twelve hours after being plated into a 96-well plate at a density of 2,000 cells/well the cells were transfected with an adenovirus. Next, the cells were incubated for 0, 24, 48 and 72 h; then, 10 µl CCK-8 solution was added to each well and the cultures were incubated at 37°C for 1 h. Subsequently, the absorbance at 450 nm was measured.
Statistical analysis
All statistical analyses were performed using SPSS version 19.0. The quantitative data were first evaluated on whether they followed the normal distribution by the Shapiro-Wilk test. The data with a non-normal distribution were analyzed using the Kruskal-Wallis test. The data with a normal distribution were assessed using the Student's t-test. A P-value <0.05 was considered to be a statistically significant difference.
Results
ANG is expressed in SQCLC and positively correlates with a high grade of malignancy of SQCLC
Immunohistochemical assays showed that ANG was expressed in the SQCLC tissues, while it was not detected in the normal lung tissues adjacent to tumors (Fig. 1A). As shown in Fig. 1B, ANG was significantly increased in the SQCLC tissues compared with that noted in the normal lung tissues (P<0.0001). Notably, high-grade SQCLC which indicates a higher postoperative surgical-pathologic staging exhibited the strongest ANG expression (Fig. 1A). Consistently, the difference in the patterns of ANG expression in low-grade and high-grade SQCLC was significant (low-grade vs. high-grade, P<0.0001, Fig. 1C), which showed that a high percentage of high-grade SQCLC cases had strong ANG expression when compared with the expression in its low-grade counterpart. Collectively, our results indicated that ANG expression increased with the malignant grade of SQCLC.
Upregulation of ANG enhances proliferation, migration and invasion of SK-MES-1 cells in vitro
Since the local expression level of ANG was considerably increased in the SQCLC tissues, especially in the cancerous tissues from high-grade SQCLC patients where ANG expression was intensely positive, as compared with the adjacent normal tissue, we considered that ANG may play an important role in the development, metastasis and invasiveness of SQCLC. To investigate the effect of ANG on SQCLC, we used an in vitro system. Firstly, we effectively infected SK-MES-1 cells with Ad-ANG (Fig. 2A). Evaluation of cell proliferation was performed after infection using a CCK-8 assay kit. It was found that Ad-ANG SK-MES-1 cells manifested increased proliferation levels at 24, 48 and 72 h after infection (Fig. 2C). With regard to SK-MES-1 cell migration and invasion capability evaluation, scratch assay and invasion chamber assays were applied to assess the impact of ANG on these cell properties. Results showed that Ad-ANG SK-MES-1 cells presented not only significantly increased migration but also invasion capability (Fig. 2B and D), as compared with the Ad-Null cells.
These results definitely indicated that ANG is an important regulator of proliferation, migration and invasion in SK-MES-1 cells.
Knockdown of ANG reduces the ability of proliferation, migration and invasion of SK-MES-1 cells in vitro
We further used shANG to knock down ANG in SK-MES-1 cells. The cells were infected with shANG and cultured for 48 h. SK-MES-1 cells infected with shScramble were used as a negative control. Compared with the shScramble SK-MES-1 cells, the expression level of ANG mRNA in the shANG cells was decreased by 70% (Fig. 3A). Western blot analysis results also confirmed lower expression level of ANG in the shANG SK-MES-1 cells (Fig. 3A). Furthermore, it was revealed that the shANG SK-MES-1 cells showed decreased proliferation capability (Fig. 3C). Meanwhile, decreased migration and invasion capacities were also observed in the shANG SK-MES-1 cells, as compared with the shScramble SK-MES-1 cells (Fig. 3B and D).
EMT is associated with the grade of malignancy of SQCLC
Given the fact that EMT contributes to metastasis and invasiveness of various cancers, we examined the expression of several EMT markers in both low-grade and high-grade SQCLC tissues. As shown in Fig. 4, compared with low-grade SQCLC, epithelial markers including E-cadherin and β-catenin were significantly reduced, while mesenchymal markers including N-cadherin, vimentin and TGF-β1 were markedly enhanced in the high-grade SQCLC, indicating that EMT may contribute to a metastatic and aggressive phenotype of SQCLC.
Overexpression of ANG upregulates the expression of mesenchymal markers but downregulates epithelial markers in the SK-MES-1 cell line
After showing that both ANG and EMT were positively correlated with a high grade of malignancy of SQCLC, we further tested whether ANG induces the metastatic and invasive phenotype of SQCLC by augmenting EMT. As shown in Fig. 5A, we found that the E-cadherin staining was decreased while N-cadherin staining was increased in the Ad-ANG SK-MES-1 cells as compared with the Ad-Null cells. Furthermore, western blot analysis confirmed that the expression of vimentin and TGF-β1 was significantly enhanced in the Ad-ANG cells. In contrast, Ad-ANG SK-MES-1 cells exhibited a lower level of protein expression of epithelial markers including E-cadherin and β-catenin, as compared with the Ad-Null and negative control groups (Fig. 5B and C, respectively; P<0.01). These data indicated that ANG triggers the process of EMT in SK-MES-1 cells.
Discussion
ANG, a 14.4 kDa polypeptide, was first isolated from serum-free supernatants of a human adenocarcinoma cell line, HT-29 (15). In addition to angiogenic activity, ANG is also implicated in a variety of biological functions including cell growth, proliferation, migration and tube formation (6,8,16). Of note, some studies have reported that ANG can undergo nuclear translocation to stimulate rRNA transcription in both cancer cells and cancer-associated endothelial cells (17). Recent research has shown that the expression and activity of ANG are upregulated in many human tumors including breast, kidney, colorectal and lung cancers (18). In the present study, immunohistochemical assays showed that ANG was expressed in SQCLC tissues, while it was not expressed in normal lung tissues adjacent to tumors, indicating that ANG is involved in the development of SQCLC, which is consistant with the finding that increased ANG is positively associated with the incidence of human tumors.
ANG has been reported as a member of the urokinase plasminogen activator receptor interactome that participates in the formation of plasmin and the migration of breast cancer cells, which are necessary for tumor metastasis and invasion (19). In a clinical study, researchers found that, among the markers representing different aspects of cancer vascular biology and exhibiting abnormal expression in colorectal cancer, ANG was the only index which was independently associated with the increasing stage of colorectal cancer according to the Dukes' and American Joint Committee on Cancer systems (20). Similarly, in patients with adenocarcinoma, our previous study showed that increased expression of ANG was correlated with vascular and pleural invasion as well as positive lymph node metastasis (6). Consistently, we found that increased expression of ANG was positively correlated with the high grade of SQCLC while knockdown of ANG abrogated proliferation, migration and invasion of SK-MES-1 cells. These results from clinical specimens and cultured squamous cell lung carcinoma cell lines supported the notion that ANG contributes to the invasive phenotype of squamous cell lung carcinoma cells.
Numerous studies have demonstrated that cell invasion during tumor progression may be dependent on the acquisition of EMT features (21). Evidence from clinical studies also suggests that poor survival of cancer patients and drug-resistance are associated with EMT phenotypes in malignant cancer cells (22). EMT is a complex process during which epithelial cells lose their polarity and cell-cell adhesion, exhibit enhanced cell-extracellular matrix adhesion, gain invasive properties and become mesenchymal-like cells. In both squamous cell lung carcinoma tissues and SK-MES-1 cells, we showed that high expression of ANG was positively correlated with the expression of mesenchymal markers but negatively associated with epithelial markers. These data suggest that ANG induces EMT in squamous cell lung carcinoma. The intermediate filament protein vimentin is an important marker of EMT and a critical regulator of mesenchymal cell migration. Induction of vimentin is associated with increased expression of Axl which enhanced the migratory activity of pre-malignant breast epithelial cells (23). Cell adhesion molecules are important to cancer invasion and metastasis. E-cadherin to N-cadherin switch was found to promote cancer progression via TGF-β-induced EMT in extrahepatic cholangiocarcinoma (24) and is of strong importance in the progression of prostate cancer (25). In lung cancer cell line, H1650ER, N-cadherin expression was also reported to be upregulated and paralleled by the reduced expression of E-cadherin. Proliferation and invasion of H1650ER cells were inhibited by knockdown of N-cadherin (26). In accordance with these previous studies, our results indicated that overexpression of ANG led to the upregulation of vimentin, fibronectin and N-cadherin and reduced expression of E-cadherin, suggesting that ANG contributes to invasion and metastasis of lung carcinoma by inducing EMT.
Many molecular and cell signaling pathways have been reported to participate in the EMT process. For instance, accumulating evidence indicates that the phosphatidylinositol 3-kinase (PI3K)/Akt/mTOR pathway plays an important role in EMT (27,28). The MAPK/ERK pathway has also been demonstrated to be critical for many features of EMT including acquisition of invasive properties, enhanced MMP activity, and attenuation of adherens junctions. EMT mediated by TGF-β also involves the activation of the MAPK/ERK pathway (29). In addition, research has shown that receptor activator of NF-κB (RANK) can induce EMT in human mammary epithelial cells and promotes oncogenesis and metastasis (30). Notably, correlation of ANG and these cell signaling pathways has been demonstrated in many studies. Overexpression of ANG can activate phosphorylation of downstream molecules of the PI3K/AKT/mTOR signaling pathway in bladder cancer cells (31). In cultured human umbilical vein endothelial cells, ANG induced the activation of both ERK1/2 and SAPK/JNK (32,33). Moreover, ANG prevented stress-induced death of P19 embryonal carcinoma cells via upregulation of the Bcl-2 and NF-κB pathways (34). Given these results from extensive studies, we speculate that ANG may induce EMT via a complex regulating network involving various cell signaling pathways.
In summary, this study suggests that ANG promotes the invasion and metastasis of SQCLC by enhancing proliferative, migratory and invasive ability of squamous cell carcinoma cells through the induction of EMT. Our results highlight the possibility that ANG may serve as a target for the treatment of squamous cell carcinoma of the lung.
Abbreviations:
|
ANG |
angiogenin |
|
EMT |
epithelial-mesenchymal transition |
|
EGFR |
epidermal growth factor receptor |
|
SQCLC |
lung squamous cell carcinoma |
Acknowledgments
This study was supported by the National Natural Science Foundation of China (nos. 81272592 and 81301829).
References
|
Paez JG, Jänne PA, Lee JC, Tracy S, Greulich H, Gabriel S, Herman P, Kaye FJ, Lindeman N, Boggon TJ, et al: EGFR mutations in lung cancer: Correlation with clinical response to gefitinib therapy. Science. 304:1497–1500. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S, Fujiwara S, Watanabe H, Kurashina K, Hatanaka H, et al: Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature. 448:561–566. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Li S and Hu GF: Angiogenin-mediated rRNA transcription in cancer and neurodegeneration. Int J Biochem Mol Biol. 1:26–35. 2010.PubMed/NCBI | |
|
Nilsson UW, Abrahamsson A and Dabrosin C: Angiogenin regulation by estradiol in breast tissue: tamoxifen inhibits angiogenin nuclear translocation and antiangiogenin therapy reduces breast cancer growth in vivo. Clin Cancer Res. 16:3659–3669. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Ibaragi S, Yoshioka N, Kishikawa H, Hu JK, Sadow PM, Li M and Hu GF: Angiogenin-stimulated rRNA transcription is essential for initiation and survival of AKT-induced prostate intraepithelial neoplasia. Mol Cancer Res. 7:415–424. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Yuan Y, Wang F, Liu XH, Gong DJ, Cheng HZ and Huang SD: Angiogenin is involved in lung adenocarcinoma cell proliferation and angiogenesis. Lung Cancer. 66:28–36. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Ivanov P, Emara MM, Villen J, Gygi SP and Anderson P: Angiogenin-induced tRNA fragments inhibit translation initiation. Mol Cell. 43:613–623. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Li S and Hu GF: Emerging role of angiogenin in stress response and cell survival under adverse conditions. J Cell Physiol. 227:2822–2826. 2012. View Article : Google Scholar : | |
|
Polyak K and Weinberg RA: Transitions between epithelial and mesenchymal states: Acquisition of malignant and stem cell traits. Nat Rev Cancer. 9:265–273. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al: The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Zeisberg M and Neilson EG: Biomarkers for epithelial-mesenchymal transitions. J Clin Invest. 119:1429–1437. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Kokkinos MI, Wafai R, Wong MK, Newgreen DF, Thompson EW and Waltham M: Vimentin and epithelial-mesenchymal transition in human breast cancer-observations in vitro and in vivo. Cells Tissues Organs. 185:191–203. 2007. View Article : Google Scholar | |
|
Kurozumi A, Kato M, Goto Y, Matsushita R, Nishikawa R, Okato A, Fukumoto I, Ichikawa T and Seki N: Regulation of the collagen cross-linking enzymes LOXL2 and PLOD2 by tumor-suppressive microRNA-26a/b in renal cell carcinoma. Int J Oncol. 48:1837–1846. 2016.PubMed/NCBI | |
|
Hu K, Tian Y, Du Y, Huang L, Chen J, Li N, Liu W, Liang Z and Zhao L: Atrazine promotes RM1 prostate cancer cell proliferation by activating STAT3 signaling. Int J Oncol. 48:2166–2174. 2016.PubMed/NCBI | |
|
Fett JW, Strydom DJ, Lobb RR, Alderman EM, Bethune JL, Riordan JF and Vallee BL: Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry. 24:5480–5486. 1985. View Article : Google Scholar : PubMed/NCBI | |
|
Miyake M, Goodison S, Lawton A, Gomes-Giacoia E and Rosser CJ: Angiogenin promotes tumoral growth and angiogenesis by regulating matrix metallopeptidase-2 expression via the ERK1/2 pathway. Oncogene. 34:890–901. 2015. View Article : Google Scholar : | |
|
Li L, Pan XY, Shu J, Jiang R, Zhou YJ and Chen JX: Ribonuclease inhibitor up-regulation inhibits the growth and induces apoptosis in murine melanoma cells through repression of angiogenin and ILK/PI3K/AKT signaling pathway. Biochimie. 103:89–100. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Shu J, Huang M, Tian Q, Shui Q, Zhou Y and Chen J: Down-regulation of angiogenin inhibits the growth and induces apoptosis in human bladder cancer cells through regulating AKT/mTOR signaling pathway. J Mol Histol. 46:157–171. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Dutta S, Bandyopadhyay C, Bottero V, Veettil MV, Wilson L, Pins MR, Johnson KE, Warshall C and Chandran B: Angiogenin interacts with the plasminogen activation system at the cell surface of breast cancer cells to regulate plasmin formation and cell migration. Mol Oncol. 8:483–507. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Ramcharan SK, Lip GY, Stonelake PS and Blann AD: Angiogenin outperforms VEGF, EPCs and CECs in predicting Dukes' and AJCC stage in colorectal cancer. Eur J Clin Invest. 43:801–808. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Makker A and Goel MM: Tumor progression, metastasis, and modulators of epithelial-mesenchymal transition in endometrioid endometrial carcinoma: An update. Endocr Relat Cancer. 23:R85–R111. 2016. View Article : Google Scholar | |
|
Mitra A, Mishra L and Li S: EMT, CTCs and CSCs in tumor relapse and drug-resistance. Oncotarget. 6:10697–10711. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Vuoriluoto K, Haugen H, Kiviluoto S, Mpindi JP, Nevo J, Gjerdrum C, Tiron C, Lorens JB and Ivaska J: Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer. Oncogene. 30:1436–1448. 2011. View Article : Google Scholar | |
|
Araki K, Shimura T, Suzuki H, Tsutsumi S, Wada W, Yajima T, Kobayahi T, Kubo N and Kuwano H: E/N-cadherin switch mediates cancer progression via TGF-β-induced epithelial-to-mesenchymal transition in extrahepatic cholangiocarcinoma. Br J Cancer. 105:1885–1893. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Gravdal K, Halvorsen OJ, Haukaas SA and Akslen LA: A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer. Clin Cancer Res. 13:7003–7011. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang X, Liu G, Kang Y, Dong Z, Qian Q and Ma X: N-cadherin expression is associated with acquisition of EMT phenotype and with enhanced invasion in erlotinib-resistant lung cancer cell lines. PLoS One. 8:e576922013. View Article : Google Scholar : PubMed/NCBI | |
|
Berg A, Hoivik EA, Mjøs S, Holst F, Werner HM, Tangen IL, Taylor-Weiner A, Gibson WJ, Kusonmano K, Wik E, et al: Molecular profiling of endometrial carcinoma precursor, primary and metastatic lesions suggests different targets for treatment in obese compared to non-obese patients. Oncotarget. 6:1327–1339. 2015. View Article : Google Scholar : | |
|
Hipp S, Walch A, Schuster T, Losko S, Laux H, Bolton T, Höfler H and Becker KF: Activation of epidermal growth factor receptor results in snail protein but not mRNA overexpression in endometrial cancer. J Cell Mol Med. 13:3858–3867. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Edme N, Downward J, Thiery JP and Boyer B: Ras induces NBT-II epithelial cell scattering through the coordinate activities of Rac and MAPK pathways. J Cell Sci. 115:2591–2601. 2002.PubMed/NCBI | |
|
Palafox M, Ferrer I, Pellegrini P, Vila S, Hernandez-Ortega S, Urruticoechea A, Climent F, Soler MT, Muñoz P, Viñals F, et al: RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis. Cancer Res. 72:2879–2888. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Peng Y, Li L, Huang M, Duan C, Zhang L and Chen J: Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway in bladder cancer cells. Cell Signal. 26:2782–2792. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Xu Z, Monti DM and Hu G: Angiogenin activates human umbilical artery smooth muscle cells. Biochem Biophys Res Commun. 285:909–914. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Liu S, Yu D, Xu ZP, Riordan JF and Hu GF: Angiogenin activates Erk1/2 in human umbilical vein endothelial cells. Biochem Biophys Res Commun. 287:305–310. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Li S, Yu W, Kishikawa H and Hu GF: Angiogenin prevents serum withdrawal-induced apoptosis of P19 embryonal carcinoma cells. FEBS J. 277:3575–3587. 2010. View Article : Google Scholar : PubMed/NCBI |
